Company / EPS (Basic)
CME Group EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$11.18
FY2025
5-year range
$7.30 / $11.18
FY2021-FY2025
Trend
+15.4%
vs FY2024
Sector context
#43 of 387
Financials
What the data says
CME Group's eps (basic) of $11.18 is higher than 89% of companies in the Financials sector (FY2025). EPS (Basic) has increased for 5 consecutive years, from $5.73 in FY2020 to $11.18 in FY2025.
Based on SEC 10-K filings.
11.18 in FY2025 with a 5-year CAGR of +14.3%. Top quartile in the Financials sector.
Improved from $8.87 to $11.18 over the past 2 years.
Financials sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +14.7%
- 5-Year CAGR
- +14.3%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in FinancialsTop 11% of 387This company $11.18 Sector average $5.93
▼
+88.4% above sector average
Key checks
Key Insights
- CME Group's eps (basic) has grown for 5 consecutive years.
- In FY2025, eps (basic) increased 15.4% year-over-year.
- Ranks #43 out of 387 companies in the Financials sector.
- Peak eps (basic) was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.18 | +15.4% |
| FY2024 | $9.69 | +9.2% |
| FY2023 | $8.87 | +19.7% |
| FY2022 | $7.41 | +1.5% |
| FY2021 | $7.30 | +27.4% |
| FY2020 | $5.73 | -52.3% |
| FY2019 | $12.00 | +109.4% |
| FY2018 | $5.73 | -52.3% |
| FY2017 | $12.00 | +163.7% |
| FY2016 | $4.55 | +54.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026